Discriminatory power of common genetic variants in personalized breast cancer diagnosis

Yirong Wu; Craig K. Abbey; Jie Liu; Irene Ong; Peggy Peissig; Adedayo A. Onitilo; Jun Fan; Ming Yuan; Elizabeth S. Burnside

doi:10.1117/12.2217030

24 March 2016 Discriminatory power of common genetic variants in personalized breast cancer diagnosis

Yirong Wu, Craig K. Abbey, Jie Liu, Irene Ong, Peggy Peissig, Adedayo A. Onitilo, Jun Fan, Ming Yuan, Elizabeth S. Burnside

Author Affiliations +

Proceedings Volume 9787, Medical Imaging 2016: Image Perception, Observer Performance, and Technology Assessment; 978706 (2016) https://doi.org/10.1117/12.2217030
Event: SPIE Medical Imaging, 2016, San Diego, California, United States

Abstract

Technology advances in genome-wide association studies (GWAS) has engendered optimism that we have entered a new age of precision medicine, in which the risk of breast cancer can be predicted on the basis of a person’s genetic variants. The goal of this study is to evaluate the discriminatory power of common genetic variants in breast cancer risk estimation. We conducted a retrospective case-control study drawing from an existing personalized medicine data repository. We collected variables that predict breast cancer risk: 153 high-frequency/low-penetrance genetic variants, reflecting the state-of-the-art GWAS on breast cancer, mammography descriptors and BI-RADS assessment categories in the Breast Imaging Reporting and Data System (BI-RADS) lexicon. We trained and tested naïve Bayes models by using these predictive variables. We generated ROC curves and used the area under the ROC curve (AUC) to quantify predictive performance. We found that genetic variants achieved comparable predictive performance to BI-RADS assessment categories in terms of AUC (0.650 vs. 0.659, p-value = 0.742), but significantly lower predictive performance than the combination of BI-RADS assessment categories and mammography descriptors (0.650 vs. 0.751, p-value < 0.001). A better understanding of relative predictive capability of genetic variants and mammography data may benefit clinicians and patients to make appropriate decisions about breast cancer screening, prevention, and treatment in the era of precision medicine.

Citation Download Citation

Yirong Wu, Craig K. Abbey, Jie Liu, Irene Ong, Peggy Peissig, Adedayo A. Onitilo, Jun Fan, Ming Yuan, and Elizabeth S. Burnside "Discriminatory power of common genetic variants in personalized breast cancer diagnosis", Proc. SPIE 9787, Medical Imaging 2016: Image Perception, Observer Performance, and Technology Assessment, 978706 (24 March 2016); https://doi.org/10.1117/12.2217030

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available